Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:acquisition |
Pharma Tech Solutions
|
| gptkbp:awards |
Best Pharma Company 2021
|
| gptkbp:ceo |
John Goldmann
|
| gptkbp:clinical_trial |
Ongoing
|
| gptkbp:employees |
500+
|
| gptkbp:focus |
gptkb:Research_and_Development
|
| gptkbp:founded |
gptkb:1990
|
| gptkbp:headquarters |
gptkb:Germany
|
| https://www.w3.org/2000/01/rdf-schema#label |
Goldmann Pharma
|
| gptkbp:industry |
Pharmaceuticals
|
| gptkbp:market |
Global
|
| gptkbp:partnerships |
Various Healthcare Organizations
|
| gptkbp:products |
Prescription Drugs
|
| gptkbp:regulatory_compliance |
FDA Approved
|
| gptkbp:research_areas |
gptkb:Cardiology
gptkb:Oncology Neurology |
| gptkbp:revenue |
$200 million (2022)
|
| gptkbp:social_responsibility |
Community Health Initiatives
|
| gptkbp:subsidiaries |
Goldmann Biotech
|
| gptkbp:sustainability_initiatives |
Green Manufacturing Practices
|
| gptkbp:website |
www.goldmannpharma.com
|
| gptkbp:bfsParent |
gptkb:Goldmann
|
| gptkbp:bfsLayer |
7
|